Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

9,404 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
The present and future of prostate cancer urine biomarkers.
Rigau M, Olivan M, Garcia M, Sequeiros T, Montes M, Colás E, Llauradó M, Planas J, Torres Id, Morote J, Cooper C, Reventós J, Clark J, Doll A. Rigau M, et al. Among authors: clark j. Int J Mol Sci. 2013 Jun 17;14(6):12620-49. doi: 10.3390/ijms140612620. Int J Mol Sci. 2013. PMID: 23774836 Free PMC article. Review.
Biomarker and translational prostate cancer research.
Doll A, Clark J, Nelson C. Doll A, et al. Among authors: clark j. Biomed Res Int. 2015;2015:309851. doi: 10.1155/2015/309851. Epub 2015 Jan 15. Biomed Res Int. 2015. PMID: 25664317 Free PMC article. No abstract available.
Methodology for the at-home collection of urine samples for prostate cancer detection.
Webb M, Manley K, Olivan M, Guldvik I, Palczynska M, Hurst R, Connell SP, Mills IG, Brewer DS, Mills R, Cooper CS, Clark J. Webb M, et al. Among authors: clark j. Biotechniques. 2020 Feb;68(2):65-71. doi: 10.2144/btn-2019-0092. Epub 2019 Nov 29. Biotechniques. 2020. PMID: 31779479 Free article. Clinical Trial.
A urine-based DNA methylation assay, ProCUrE, to identify clinically significant prostate cancer.
Zhao F, Olkhov-Mitsel E, Kamdar S, Jeyapala R, Garcia J, Hurst R, Hanna MY, Mills R, Tuzova AV, O'Reilly E, Kelly S, Cooper C; Movember Urine Biomarker Consortium; Brewer D, Perry AS, Clark J, Fleshner N, Bapat B. Zhao F, et al. Among authors: clark j. Clin Epigenetics. 2018 Nov 23;10(1):147. doi: 10.1186/s13148-018-0575-z. Clin Epigenetics. 2018. PMID: 30470249 Free PMC article.
A four-group urine risk classifier for predicting outcomes in patients with prostate cancer.
Connell SP, Yazbek-Hanna M, McCarthy F, Hurst R, Webb M, Curley H, Walker H, Mills R, Ball RY, Sanda MG, Pellegrini KL, Patil D, Perry AS, Schalken J, Pandha H, Whitaker H, Dennis N, Stuttle C, Mills IG, Guldvik I; Movember GAP1 Urine Biomarker Consortium; Parker C, Brewer DS, Cooper CS, Clark J. Connell SP, et al. Among authors: clark j. BJU Int. 2019 Oct;124(4):609-620. doi: 10.1111/bju.14811. Epub 2019 Jun 25. BJU Int. 2019. PMID: 31106513 Free PMC article.
9,404 results